Flouria raises €1.5M to scale women’s hormonal health clinic
What’s the deal? Flouria HealthDealroom has a profile for this one. Try Dealroom → has raised an investment from Healthy.CapitalDealroom has a profile for this one. Try Dealroom → to scale its women’s hormonal health platform, bringing the Dutch company’s total funding to €1.5 million.
What’s the endgame? FlouriaDealroom has a profile for this one. Try Dealroom → runs a digital clinic for hormonal conditions, including perimenopause, PMOS, and postpartum recovery. It offers doctor-led care, testing, health tracking, and personalised treatment plans.
Why now? Since launching in 2025, Flouria has supported more than 1,000 patients. The new capital will fund growth across the Netherlands and expansion into new European markets.
Chief executive officer and co-founder Jeanine van Munster framed the raise as validation of the market’s size. “Women’s hormonal health is not a niche market, it’s an underserved majority,” she said.
The signal: The round lands amid steady investor interest in women’s health, with recent deals including Tiny Health’s $33 million raise and Bird&BeDealroom has a profile for this one. Try Dealroom →’s $13 million. Flouria’s bet is that hormonal care, long treated as a specialty, is a mainstream need.
Read more: femtechinsider.com
Image credit: www.ilmicrofono.it
